Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.95
-
NAV
₹37.40
-
Fund Started
12 Nov 2018
-
Fund Size
₹2971.07 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
1 Year
2.34%
-
3 Year
21.03%
-
5 Year
13.99%
-
Equity
97.91%
-
Cash
2.09%
-
Top 10 Holdings
Ipca Laboratories Ltd. | 8.40% |
Sun Pharmaceutical Industries Ltd. | 8.25% |
Cipla Ltd. | 8.08% |
Globus Medical Inc | 7.54% |
Illumina Inc. (USA) | 7.18% |
Laurus Labs Ltd. | 5.95% |
Gland Pharma Ltd. | 5.72% |
Sai Life Sciences Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.56% |
Cohance Lifesciences Ltd. | 3.81% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-
